Start Date
January 31, 2010
Primary Completion Date
June 30, 2011
Study Completion Date
June 30, 2011
Ranibizumab
Ranibizumab 0.5 mg intravitreal injection
Kresge Eye Institute, Detroit
Lead Sponsor
Collaborators (1)
Wayne State University
OTHER
Genentech, Inc.
INDUSTRY
Kresge Eye Institute
OTHER